Symbiotec Pharmalab

Quarterly
Consolidated
ParticularsJun '25Mar '26Jun '26
Revenue205.81245.41218.49
Expenses160.99210.17200.96
EBITDA60.6162.2545.53
EBIT50.1042.5123.71
Profit Before Tax44.8235.2417.53
Net Profit29.9227.5314.06
Financial Ratios
Operating Profit Margin29.83%25.38%20.88%
Net Profit Margin14.73%11.22%6.45%
Earning Per Share (Diluted)5.344.762.24
Dividends Per Share0.000.000.00